Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Amifostine may be an effective treatment for the toxic side effects caused by
radiation therapy and chemotherapy. It is not yet known whether chemotherapy and radiation
therapy are more effective with or without amifostine for non-small cell lung cancer.
PURPOSE: Randomized phase III trial to determine the effectiveness of amifostine in treating
patients who have stage II or stage III non-small cell lung cancer that cannot be surgically
removed and who are undergoing chemotherapy and radiation therapy.